Ultragenyx Shareholder Alert: ClaimsFiler Reminds Investors With Losses In Excess Of $100,000 Of Lead Plaintiff Deadline In Class Action Lawsuit Against Ultragenyx Pharmaceutical Inc. - RARE

Core Viewpoint - ClaimsFiler is reminding investors about the deadline for filing lead plaintiff applications in a securities class action lawsuit against Ultragenyx Pharmaceutical Inc. [1] Group 1: Lawsuit Details - The deadline for filing lead plaintiff applications is April 6, 2026 [1] - The class action lawsuit pertains to investors who purchased or acquired shares of Ultragenyx between August 3, 2023, and December 26, 2025 [1] - The lawsuit is currently pending in the United States District Court for the Southern District of New York [1]